Site Overlay


The 14th edition EMD Serono’s Specialty Digest continues its. Getting the picture of what’s happening now is the value of. Managed Markets, EMD Serono, Inc. Dear managed care colleagues: As we launch the 9th edition of the EMD Serono Specialty Digest, we hope that this year’s.

Author: Kisho Muzil
Country: Myanmar
Language: English (Spanish)
Genre: Career
Published (Last): 28 February 2010
Pages: 176
PDF File Size: 1.22 Mb
ePub File Size: 12.39 Mb
ISBN: 607-8-42247-933-9
Downloads: 87147
Price: Free* [*Free Regsitration Required]
Uploader: Grogal

Stepping Stones for Innovation. Medicine Spending in Next Decade. Your Contact Melissa Beglin, View original content with multimedia: Cure Rates Are Rising.

EMD Serono Specialty Digest: health plans’ ongoing cost struggle – Pharmaceutical Commerce

Growth in Medicine Prices. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. Welcome to our new site. Reductions in Hep C Complications. Medicines Offer Cost Containment. Table of contents Easily move through the document, finding the part you want in the convenient table of contents. Slowdown in Medicine Spending. The Dihest is available to those who request a copy at http: The specialty pharmacy landscape is serlno changing.


EMD Serono Specialty Digest™ 14th Edition

Better Use of Medicines. Of those that do not have a site-of-care program, more than half plan to implement one in the next 12 months. Originally developed in to serve as a reference and benchmarking tool for managed care decision makers, the EMD Serono Specialty Digest has been accessed and used annually by thousands of stakeholders, including health plans, pharmacy benefit managers, employers, specialty pharmacies, and pharmaceutical companies.

Powerful Tools to Reduce Spending. Medicines Improve Quality of Life. Astronics – Systemes Luminescent Canada Inc.

The survey, which was fielded from November 15, to December 28,measured the use of common drug benefit management tools, emerging challenges and opportunities, and assessments of the success of various initiatives.

Challenging the US in Innovation. Among the interesting trends identified this year: Increases in US Life Expectancy. Patients Facing High Cost Sharing. Most Common Prescribing Problem.

Seventy-six percent of plans cover injectable drugs under the pharmacy benefit only. A Decade of Advances. The Complexity of Clinical Trials. View original content with multimedia: The Digest is an annual industry resource that provides market data on pharmacy benefit manager PBM and health insurance plans’ management of biopharmaceuticals and identifies common trends occurring across plans.


Innovation in Rare Diseases. Rebates Reduced Price Growth. Translating Science into Medicines. Drug Development Costs Doubling.

PhRMA | Chart Packs

The founding family remains the majority owner of the publicly listed corporate group. Drug Discovery and Development. Significant Value to Communities. New areas of focus for Today, the business has 1, employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts. Pragmatic Solutions to Address Cost. We are working hard to be a leader in identifying current and future trends in the management of specialty pharmaceuticals.

Commercial Success of Digwst Meds. Clinical Factors Drive Presciptions. State Targeting in Economic Plans.

Spending on Cancer Medicines. Total Health Care Spending Growth. US Access to Cancer Medicines. Find out what’s going to be top of mind in the coming year. Brand Medicine Spending Rebates. Patent Challenges by Generics. Leading in Intellectual Property.